Subcutaneous palivizumab (Synagis®) administration in an infant with congenital type 2B von Willebrand disease

Intramuscular injections are contra-indicated in infants with either acquired or congenital bleeding disorders. In such patients, it is unlicensed practice to administer vaccines by subcutaneous route. However, there are no reports on subcutaneous administration of palivizumab (Synagis®). We report...

Full description

Saved in:
Bibliographic Details
Main Authors: Karel Allegaert (Author), Maissa Rayyan (Author), Veerle Cossey (Author), Chris Van Geet (Author)
Format: Book
Published: Hygeia Press di Corridori Marinella, 2015-01-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available